Diabetes By The Numbers

Welcome to Episode Ten of Diabetes By the Numbers.Today we have our first returning guest.  It's Molly McElwee Malloy, Head of Patient Engagement at TypeZero Technologies in Charlottesville, Virginia.  TypeZero is in the news this week for two big undertakings.First, there's a 12.7 million dollar artificial pancreas study funded by the National Institutes of Health.  It will begin very soon.  In this study, they'll be testing TypeZero's inControl platform, using a spiffy new device. This study will include as many as 240 participants!  The studies will take place in nine locations... six in the USA, and three in Europe.  To find out more about participating in this important research, scroll to the bottom of this post.The second big piece of news is this: Type Zero is entering into a partnership with CellNovo, which makes an integrated diabetes management system in Europe.  They've gotten a lot of good press here in the USA, and we talk about that and what this partnership means for TypeZero.  Have a listen.